Canada Life
XENE icon

Canada Life’s Xenon Pharmaceuticals XENE Stock Holding History

Canada Life’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$411K Hold
7,024
– – ﹤0.01% 1528
2025
Q4 		$315K Hold
7,024
– – ﹤0.01% 1570
2025
Q3 		$274K Hold
7,024
– – ﹤0.01% 1672
2025
Q2 		$220K Hold
7,024
– – ﹤0.01% 1697
2025
Q1 		$236K Sell
7,024
-8,887
-56% -$337K ﹤0.01% 1709
2024
Q4 		$623K Hold
15,911
– – ﹤0.01% 1595
2024
Q3 		$628K Hold
15,911
– – ﹤0.01% 1632
2024
Q2 		$621K Buy
15,911
+5,879
+59% +$235K ﹤0.01% 1628
2024
Q1 		$432K Buy
10,032
+4,691
+88% +$216K ﹤0.01% 1718
2023
Q4 		$244K Buy
5,341
+848
+19% +$30K ﹤0.01% 1809
2023
Q3 		$153K Buy
4,493
+2,800
+165% +$105K ﹤0.01% 1895
2023
Q2 		$66K Sell
1,693
-699
-29% -$27.8K ﹤0.01% 1979
2023
Q1 		$86K Hold
2,392
– – ﹤0.01% 1996
2022
Q4 		$95K Hold
2,392
– – ﹤0.01% 1996
2022
Q3 		$86K Buy
2,392
+535
+29% +$19.2K ﹤0.01% 2015
2022
Q2 		$56K Hold
1,857
– – ﹤0.01% 2040
2022
Q1 		$60K Hold
1,857
– – ﹤0.01% 2114
2021
Q4 		$58K Buy
1,857
+753
+68% +$22.5K ﹤0.01% 2138
2021
Q3 		$17K Hold
1,104
– – ﹤0.01% 2469
2021
Q2 		$21K Sell
1,104
-1,313
-54% -$24.2K ﹤0.01% 2479
2021
Q1 		$43K Hold
2,417
– – ﹤0.01% 2337
2020
Q4 		$37K Hold
2,417
– – ﹤0.01% 2386
2020
Q3 		$27K Hold
2,417
– – ﹤0.01% 2365
2020
Q2 		$30K Buy
+2,417
New +$30.8K ﹤0.01% 2402

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Canada Life's XENE Position: Q1 2026 in Review

Canada Life held its Xenon Pharmaceuticals (XENE) position steady in Q1 2026 at 7,024 shares worth $411K. The position accounts for ﹤0.01% of the portfolio, ranked #1528.

Canada Life first reported a position in XENE in Q2 2020 and has held it in 24 quarters since. The position peaked at $628K in Q3 2024. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

  • Canada Life held 7,024 shares of Xenon Pharmaceuticals worth $411K as of Q1 2026.
  • Canada Life left its Xenon Pharmaceuticals share count unchanged in Q1 2026.
  • Xenon Pharmaceuticals made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1528 holding.
  • Canada Life first reported a position in Xenon Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
  • Canada Life's Xenon Pharmaceuticals position peaked at $628K in Q3 2024.
  • 290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.